Literature DB >> 16727474

In vitro fertilization and culture of ova from heifers infected with bovine herpesvirus-1 (BHV-1).

A Bielanski1, C Dubuc.   

Abstract

Oocytes collected from heifers infected experimentally with bovine herpesvirus-1 (BHV-1, 10(8) TCID(50)/ml) and from dexamethasone-treated (stressed) BHV-1 seropositive animals were matured, fertilized and co-cultured in vitro for 7 d prior to being tested for the presence of the virus. Nineteen of the 21 infected donors yielded embryos and follicular fluids that were BHV-1 positive. Oviductal cells (17 21 ) and uterine fluids (14 21 ) were also positive. Titers for the positive samples ranged 10(1.6)-10(9.6) TCID(50)/ml. The cleavage rate and the proportion of blastocysts that developed from oocytes of BHV-1 infected animals were 26% (n=361) and 6% compared with 56% (n=112) and 26% for uninfected control donors (P<0.05). In contrast, embryos produced from dexamethasone-treated animals tested negative for BHV-1 and yielded 11% blastocysts as compared with 25% for the control group. The results indicate that transferable-stage embryos can be produced by IVF from infected BHV-1 animals and that such embryos are associated with the virus, and might have potential for disease transmission.

Entities:  

Year:  1994        PMID: 16727474     DOI: 10.1016/0093-691x(94)90478-2

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  2 in total

1.  An attempt to render oocytes and embryos free from the porcine circovirus type 2 after experimental in vitro exposure.

Authors:  Andrzej Bielanski; Renée Larochelle; Ronald Magar
Journal:  Can J Vet Res       Date:  2004-07       Impact factor: 1.310

2.  Impact of Overuse and Sexually Transmitted Infections on Seminal Parameters of Extensively Managed Bulls.

Authors:  Giovanni Montoya-Monsalve; María-Jesús Sánchez-Calabuig; Javier Blanco-Murcia; Laura Elvira; Alfonso Gutiérrez-Adán; Priscila Ramos-Ibeas
Journal:  Animals (Basel)       Date:  2021-03-15       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.